Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.052 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.055 | 0.7 |